These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 35843942)

  • 21. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into N6-methyladenosine and programmed cell death in cancer.
    Liu L; Li H; Hu D; Wang Y; Shao W; Zhong J; Yang S; Liu J; Zhang J
    Mol Cancer; 2022 Jan; 21(1):32. PubMed ID: 35090469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of N
    Zhang L; Hou C; Chen C; Guo Y; Yuan W; Yin D; Liu J; Sun Z
    Mol Cancer; 2020 Jun; 19(1):105. PubMed ID: 32522202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications.
    Wang D; Zhang Y; Li Q; Zhang A; Xu J; Li Y; Li W; Tang L; Yang F; Meng J
    Biomed Pharmacother; 2023 Nov; 167():115477. PubMed ID: 37696088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA N6-methyladenosine: a new player in autophagy-mediated anti-cancer drug resistance.
    Paramasivam A; Priyadharsini JV
    Br J Cancer; 2021 May; 124(10):1621-1622. PubMed ID: 33723389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interplay between m6A RNA methylation and noncoding RNA in cancer.
    Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
    J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functions of RNA N6-methyladenosine modification in cancer progression.
    Chen B; Li Y; Song R; Xue C; Xu F
    Mol Biol Rep; 2019 Apr; 46(2):2567-2575. PubMed ID: 30911972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel insights into the interplay between m6A modification and programmed cell death in cancer.
    Chen J; Ye M; Bai J; Hu C; Lu F; Gu D; Yu P; Tang Q
    Int J Biol Sci; 2023; 19(6):1748-1763. PubMed ID: 37063421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNAs, Noncoding RNAs, and N6-methyladenosine Involved in the Development of MAFLD.
    Nakashima M; Suga N; Ikeda Y; Yoshikawa S; Matsuda S
    Noncoding RNA; 2024 Feb; 10(1):. PubMed ID: 38392966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives.
    Xu Z; Peng B; Cai Y; Wu G; Huang J; Gao M; Guo G; Zeng S; Gong Z; Yan Y
    Biochem Pharmacol; 2020 Dec; 182():114258. PubMed ID: 33017575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surmounting cancer drug resistance: New insights from the perspective of N
    Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
    Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ramifications of m6A Modification on ncRNAs in Cancer.
    Mehmood R
    Curr Genomics; 2024 May; 25(3):158-170. PubMed ID: 39087001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of N6-methyladenosine modification of circRNAs in glioblastoma.
    Zhang Y; Geng X; Xu J; Li Q; Hao L; Zeng Z; Xiao M; Song J; Liu F; Fang C; Wang H
    J Cell Mol Med; 2021 Aug; 25(15):7204-7217. PubMed ID: 34180136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functions of RNA N6-methyladenosine modification in cancer progression.
    Chen B; Li Y; Song R; Xue C; Xu F
    Mol Biol Rep; 2019 Feb; 46(1):1383-1391. PubMed ID: 30788764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
    Liang Z; Kidwell RL; Deng H; Xie Q
    Cancer Biol Med; 2020 Feb; 17(1):9-19. PubMed ID: 32296573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.
    Wang Q; Liang Y; Luo X; Liu Y; Zhang X; Gao L
    Exp Neurol; 2021 Nov; 345():113829. PubMed ID: 34339678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research Advances in the Roles of N6-Methyladenosine Modification in Ovarian Cancer.
    Zhang Y; Ling Y; Zhou Y; Shi X; Shen F; Zhou J; Chen Y; Yang F; Gu Y; Wang J
    Cancer Control; 2024; 31():10732748241256819. PubMed ID: 38755968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.
    Huang W; Chen TQ; Fang K; Zeng ZC; Ye H; Chen YQ
    J Hematol Oncol; 2021 Jul; 14(1):117. PubMed ID: 34315512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance.
    Cui C; Yang J; Li X; Liu D; Fu L; Wang X
    Mol Cancer; 2020 Mar; 19(1):58. PubMed ID: 32171304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interaction between m6A modification and noncoding RNA in tumor microenvironment on cancer progression.
    Wei L; Liu S; Xie Z; Tang G; Lei X; Yang X
    Int Immunopharmacol; 2024 Oct; 140():112824. PubMed ID: 39116490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.